| HOME >> BIOLOGY >> TECHNOLOGY |
MONTREAL, June 2 /PRNewswire/ -- The Scarborough Hospital (TSH), Canada's largest urban community hospital, has selected Chyma(TM) to help improve on-call scheduling and communications between physicians. The implementation of Chyma(TM) for their team of more than 700 physicians has begun with the busy ER departments at the two hospital campuses and will soon be expanding to the department of general medicine.
"Chyma(TM) reflects the commitment of the Scarborough Hospital (TSH) to excellent patient care, and leadership among Canadian hospitals through the adoption of innovative healthcare information technology," said Jeanie Joaquin, Vice President of Patient Services at the TSH. "Equally important, Chyma(TM) supports our medical team in a meaningful way by giving them a tool to save valuable time in the on-call scheduling process. As an added benefit, we believe that Chyma(TM) better positions TSH to attract doctors and locums in our community while enabling our physicians to better manage their schedules and balance their lives."
"Now with a few mouse clicks, doctors and administrators using Chyma(TM) at the TSH will know in 'real time' which physician is on where and when," said Mark Gregory, Vice President of Marketing and Communications for Chyma(TM). "The technology is a visionary tool for planning for healthcare emergencies, healthcare resource allocation, and informatics."
Chyma(TM) (pronounced K-eye-ma) is a Web-based tool that enables
physicians and healthcare administrators to manage on-call schedules.
Designed by a doctor, Chyma(TM) has the features and functionality
healthcare professionals want including:
-- Rapid generation of schedules
-- Schedule grouping for multi-departments and multi-communities
-- Vacation approval
-- Conflict catcher
-- Intuitive Vista and Mac look
-- OnNow! full screen (airport style) display
-- File and 'contact' sharing, and secure email across communities
-- An optional powerful rules-based scheduling module; and
-- Fast, reliable Net 2.0 Architecture with Ajax components.
Chyma(TM) (http://www.chyma.net) is currently in use in leading hospitals in Canada including St. Michaels in Toronto, St. Joseph's and McMaster University in Hamilton, the North Bay General Hospital and the Children's Hospital and St. Justine's in Montreal as well as primary care networks (PCNs) in Alberta such as Calgary Foothills, Calgary Rural and Highlands.
Chyma(TM) is owned by IsaiX Technologies (http://www.isaix.com), a leading Montreal-based technology company with a focus on the life sciences and financial sectors.
'/>"/>
| SOURCE IsaiX Technologies Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
2. Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System
3. Researchers outline structure of largest nonvirus particle ever crystallized
4. Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the Worlds Largest, Most-Advanced Automated Pharmacy
5. The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis
6. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
7. ChanTest to Highlight Expanded Ion Channel Testing Services for Preclinical Safety at ToxExpo, Including the Worlds Largest Catalog of Validated Ion Channels, Booth 2504
8. Susan G. Komen for the Cure(R) Announces Largest Grants Slate Ever: $100 Million to Speed Delivery of Breast Cancer Discoveries, Cures
9. Cepheid Signs Group Purchasing Contract with Novation, the Nations Largest Healthcare Contracting Organization
10. DolmatConnell & Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Improving Link Between Pay and Performance
11. Oral Drug From Novartis/Mitsubishi Tanabe Will Capture the Largest Market Share of All Emerging Multiple Sclerosis Therapies in 2017
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |